Savara

Inhaled antibiotic for Methicillin-resistant Staphylococcus aureus (MRSA) infections in Cystic Fibrosis (CF) patients.

  • Stage Product In Development
  • Industry Biotechnology
  • Location United States
  • Currency USD
  • Founded August 2008
  • Employees 5
  • Website savarapharma.com

Only investors on Gust who have been granted access can view this content.

Interested in this startup? Sign In or Sign Up to request more information.

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free